Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the therapeutic activity and safety of E7389 at a dose of 1.4mg/m(2) on days 1 and 8 every 3 weeks in patients with advanced and/or metastatic soft tissue sarcoma who have relapsed following standard therapies.
Critère d'inclusion
- Advanced and/or metastatic soft tissue sarcoma